What is ESPR's P/E ratio?

ESPERION THERAPEUTICS INC (ESPR) currently trades at a P/E ratio of 13.21.

ESPERION THERAPEUTICS INC reports a Return on Equity (ROE) of 2.41%.

What is ESPR's dividend yield?

ESPERION THERAPEUTICS INC offers a dividend yield of 0.00%.

What is ESPR's Deepscope Quality Score?

Deepscope rates ESPR's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ESPR?

Deepscope's AI Timing Score for ESPR is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ESPR belong to?

ESPERION THERAPEUTICS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

Cổ phiếu ESPR (NASDAQ) | ESPERION THERAPEUTICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-18 | FS: 2026-03-31)

ESPR

ESPERION THERAPEUTICS INC

USD 3.15

-0.02 (-0.63%) Day Change

Watchlist Portfolio Compare Chart

13.21

P/E

-0.82

D/E

2.4%

ROE

-1.6%

ROA

0.00%

Div Yield

-0.21

PEG

ESPERION THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.15 Price -0.02 (-0.63%) Day Change	NEWS SCORE: 96

ESPR Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	96
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.15
PBV / Sector	-2.65 / 2.51
Earning Per Share	-0.03

PE / Sector	13.21 / 24.81
PEG or PE/Growth / Sector	-0.21 / 0.12
Average 1M Daily Value	30.83 M GREAT
Average 1W Daily Value	36.14 M GREAT

Yếu tố Kỹ thuật

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-1.77 / 15.97
NPM Average (%) / Sector	-102.49 / -16.38
NPM Change Average (%) / Sector	-66.39 / 113.36
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-1.60 / 8.16
ROA Average (%) / Sector	-43.49 / 2.38
ROA Change Average (%) / Sector	-53.00 / 108.63
ROE (%) / Sector	2.41 / -0.19
ROE Average (%) / Sector	28.28 / 7.40 GREAT
ROE Change Average (%) / Sector	-54.70 / 371.95
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.52
Dividend Average (%) / Sector	N/A / 3.07
Dividend Change Average (%) / Sector	N/A / 14.40

Chi tiết đăng ký

Analyze Date	2026-06-19 09:46:44
Symbol	ESPR
Name	ESPERION THERAPEUTICS INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	257.69 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	816.89 / 9,760.95

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108

Phone: 734 887 3903

Website: https://www.esperion.com

Employees: 294

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was formerly known as HDL Therapeutics, Inc. and changed its name to Esperion Therapeutics, Inc. in May 2008. The company was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.